Assyro AI

Orange Book product · Generic (ANDA)

DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE

Generic (ANDA)ANDA 090694TE ABRX LUPIN

At a glance

Dec 11, 2013

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 11, 2013

    12 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

DULOXETINE HYDROCHLORIDE

Strength

EQ 20MG BASE

Dosage form

CAPSULE, DELAYED REL PELLETS

Route

ORAL

TE code

AB

Application

ANDA 090694

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of DULOXETINE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.